Sunho Biologics, Inc.

HK$6.39As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2898Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 2Y CAGR (4.23%)
Div yield —
ROE (15.95%)
Biotechnology
Beta (5Y) 0.41
PE TTM —
TSR TTM (20.13%)
Mkt cap HK$970.4M
ROIC (9.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.98
24.93%
(26.27%)
Hold 5|12|2|5|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.09
0.10
33.10%
19.25%
9.38%
11.79%
Revenue¥M
64.66
64.39
65.75
66.18
13.66%
9.53%
7.10%
4.34%
Peers (US$123.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.108
(0.445)
(0.451)
EBIT/Intx
0.160
0.362
0.252
Own earn%
(74.21)
3.59
3.29
Sh yield%
29.28
39.18
40.25
Owners
Insiders/Inst%
2.21
69.11
Short interest%
1.11
SBC / revenue%
4.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
28–35
$1 testx
0.0
Incr. ROIC%
9